Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:14 AM
Ignite Modification Date:
2025-12-25 @ 4:14 AM
NCT ID:
NCT01512420
Eligibility Criteria:
Inclusion Criteria:
* Adult patients, \>/= 18 years of age
* Histologically or cytologically confirmed locally advanced or metastatic non-small cell lung cancer (NSCLC)
* Patients with known wild-type EGFR gene; patients with unknown EGFR mutation status are allowed if they fulfil the following criteria:
* squamous cell carcinoma lung cancer histology, and
* current smoker, or former smoker who has stopped smoking less than 10 years ago and has had a total of \>15 pack-years of smoking
* Eastern Cooperative Oncology Group (ECOG) performance status 0 to 2
* Patients having failed one prior chemotherapy regimen and eligible for a second-line treatment with Tarceva
Exclusion Criteria:
* Current treatment with an investigational drug or participation in another investigational study
* Severe or uncontrolled systemic disease, active infection, concomitant malignancy or a second primary malignancy except for in situ carcinoma of the cervix or adequately treated basal cell carcinoma of the skin
* Clinically active interstitial lung disease
* Recent myocardial infarction or unstable angina
* Progressive or uncontrolled brain metastases
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01512420
Study Brief:
Protocol Section:
NCT01512420